Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros


Bases de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Int J Lepr Other Mycobact Dis ; 59(2): 262-70, 1991 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-2071984

RESUMO

Laser microprobe mass analysis of single bacterial organisms allows the determination of their intrabacterial ratio of sodium-to-potassium ions and the registration of fragment ions originating from their organic bacterial cell matrices as mass fingerprint spectra. It has been established previously that the intrabacterial cation ratio provides information on the physiological state of an individual bacterial cell. In the present experiments it is also shown, with different cultivable mycobacterial species and strains (drug sensitive and resistant) exposed to various drugs, that data derived from the evaluation of the mass fingerprint spectra reflect changes in the degree of impairment. The analysis of Mycobacterium leprae derived from a limited number of skin biopsies of lepromatous/borderline lepromatous leprosy patients under World Health Organization-recommended multiple-drug therapy (WHO/MDT) showed impairment of the organisms with both of the methods of measurement in proportion to the duration of treatment except in one case. In one M. leprae population from a patient who had been treated for 19 months, the fingerprint evaluation gave the first evidence for an insufficient response to treatment. This was further confirmed by the unusual frequency distribution of the Na+,K+ ratios which revealed the existence of two subpopulations, one impaired and one unimpaired.


Assuntos
Antibacterianos/farmacologia , Hansenostáticos/farmacologia , Mycobacterium leprae/efeitos dos fármacos , Mycobacterium/efeitos dos fármacos , Potássio/análise , Sódio/análise , Resistência Microbiana a Medicamentos , Humanos , Isoniazida/farmacologia , Isoniazida/uso terapêutico , Hansenostáticos/uso terapêutico , Hanseníase Dimorfa/tratamento farmacológico , Hanseníase Dimorfa/microbiologia , Hanseníase Virchowiana/tratamento farmacológico , Hanseníase Virchowiana/microbiologia , Espectrometria de Massas , Mycobacterium/análise , Mycobacterium leprae/análise , Polimixina B/farmacologia , Polimixina B/uso terapêutico , Rifampina/farmacologia , Rifampina/uso terapêutico , Trimetoprima/farmacologia , Trimetoprima/uso terapêutico
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA